Comparative Study of the Sternal Patch System With a Conventional Holter Recorder

Sponsor
Children's National Research Institute (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT04241692
Collaborator
(none)
50
1
2
27.3
1.8

Study Details

Study Description

Brief Summary

This study will be a comparison of two externally worn recording systems for documentation of cardiac arrhythmias in symptomatic patients or patients at risk for arrhythmia. Non-invasive documentation of cardiac arrhythmias can be done using the standard electrocardiogram (ECG). This has limitations given it is performed for only a 10 sec period. Alternative methods for making longer term recording have been developed. The standard device is the 24 hour 7-lead Holter monitor. Newer technology has simplified the hardware needed to make these longer term recordings, and incorporate a self-contained recording system in a patch that is applied over the patient's chest. Little is known comparing the sensitivity, specificity and recording noise / signal artifact between the older technology (standard 24-Hour Holter monitor) and the Patch electrode.

Condition or Disease Intervention/Treatment Phase
  • Device: CarnationTM Ambulatory Monitoring Sternal ECG Patch System
  • Device: Conventional 24-Hour 7 Lead Holter Monitor Recorder
N/A

Detailed Description

Objective: Comparison of two externally worn recording systems for documentation of cardiac arrhythmias in symptomatic patients or patients at risk for arrhythmia. Non-invasive documentation of cardiac arrhythmias can be done by attempting to take a snapshot view of a patient's cardiac rhythm using the standard electrocardiogram (ECG). This has limitations given it is performed for only a 10 sec period, and requires the patient to be symptomatic at the time of the recording. Therefore, the sensitivity of this technique is very low. Alternative methods for making longer term recording have been developed and used for decades. The standard device is the 24 hour 7-lead Holter monitor. These devises are large, restrict patient mobility and require cables to be connected between the applied skin ECG electrodes placed on the patient's chest and the recording device. Newer technology has simplified the hardware needed to make these longer term recordings, and incorporate a self-contained recording system in a patch that is applied over the patient's chest. These units allow for unlimited mobility, are significantly smaller, easier to wear and have eliminated the requirement for cables to connect the electrodes with the recording device. However, little is known comparing the sensitivity, specificity and recording noise / signal artifact between the older technology (standard 24-Hour Holter monitor) and the Patch electrode.

Specific Aims:

Aim 1: Comparison of Cardiac Arrhythmia Documentation between Standard 24-Hour Holter Monitor vs. Patch Monitor To evaluate the diagnostic yield for cardiac arrhythmias between the two recording systems.

The presence and frequency (qualitative and quantitative) of cardiac arrhythmias documented by each recording system with be compared. To allow for this type of comparison, each enrolled research subject with wear both systems simultaneously.

Aim 2: Comparison of Recording Quality between Standard 24-Hour Holter Monitor vs. Patch Monitor To evaluate percentage of time ECG signal quality is poor and uninterpretable.

Aim 3: Comparison of Comfortability Between Standard 24-HourHolter Monitor vs. Patch Monitor Recording Quality To evaluate level of patient's discomfort during the application of each recording system. Since both systems will be applied at the same time it may be hard for the research subject to rank the comfortability of the two systems. We will focus in this aim at more objective measures such as skin irritation under the recording electrodes, and frequency of time during which the skin electrodes come off the patient and require re-application.

Hypotheses:

Aim 1: Comparison of Cardiac Arrhythmia Documentation between Standard 24-Hour Holter Monitor vs. Patch Monitor We hypothesize that there will be no qualitative or quantitative difference in arrhythmia frequency between the two recording techniques, i.e. that both devices will detect all spontaneous arrhythmias with similar quantitative counts of ectopic beats (+/- 5%).

Aim 2: Comparison of Recording Quality between Standard 24-Hour Holter Monitor vs. Patch Monitor We hypothesize that recording quality will be better with the Patch Monitor since there are not 7 separately applied skin electrodes and cables connecting the electrodes with the recorder, resulting in a lower percent of poor ECG signal quality.

Aim 3: Comparison of Comfortability Between Standard 24-hour Holter Monitor vs. Patch Monitor Recording Quality We hypothesize that the degree of skin irritation and level of discomfort in the region of application will be less with the Patch Monitor. We hypothesize that the ECG leads will fall off from its site of application will be less with the Patch Monitor.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
50 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
To allow for this type of comparison, each enrolled research subject will wear both systems simultaneouslyTo allow for this type of comparison, each enrolled research subject will wear both systems simultaneously
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Comparative Study of the CarnationTM Ambulatory Monitoring Sternal ECG Patch System With a Conventional 24-Hour 7 Lead Holter Monitor Recorder
Actual Study Start Date :
Nov 19, 2020
Anticipated Primary Completion Date :
Feb 1, 2023
Anticipated Study Completion Date :
Mar 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Application of Carnation Ambulatory Patch Monitoring System

The patient will wear a Standard Holter Monitor and the CAM Patch system simultaneously for 24 hours.

Device: CarnationTM Ambulatory Monitoring Sternal ECG Patch System
A newly developed cardiac rhythm monitoring system

Experimental: Application Conventional 24-Hour Holter Monitor Recorder

The patient will wear a Standard Holter Monitor and the CAM Patch system simultaneously for 24 hours.

Device: Conventional 24-Hour 7 Lead Holter Monitor Recorder
Traditional recordings made using a standard 24-hour Holter monitor.

Outcome Measures

Primary Outcome Measures

  1. Difference in Cardiac Arrhythmia Detection Between Recording Systems [24 Hours]

    The presence (yes/no) and frequency of cardiac arrhythmias will be quantitated on each recording system for comparison

  2. Difference in Signal Quality Between Recording Systems [24 Hours]

    We will quantitatively evaluate percentage of time signal quality is poor and uninterpretable with each recording system.

Secondary Outcome Measures

  1. Difference in Skin Discomfort Between Recording Systems [24 Hours]

    User will rate skin discomfort on a pre-determined scale: none, mild, moderate, severe at each site of application

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A to 35 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Any infant, child, adolescent, or young adult with one or more of the following:
  1. Syncope

  2. Pre-syncope

  3. Palpitations

  4. Management of a known or suspected cardiac arrhythmia

Exclusion Criteria:
  • Any inflamed or friable skin over the anterior thorax and upper abdomen or a sternal incision within 3 months from the date of enrollment

Contacts and Locations

Locations

Site City State Country Postal Code
1 Children's National Hospital Washington District of Columbia United States 20010

Sponsors and Collaborators

  • Children's National Research Institute

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Jeffrey Moak, Jeffrey P. Moak, MD, Director, Electrophysiology and Pacing; Principle Investigator, Professor of Pediatrics, Children's National Research Institute
ClinicalTrials.gov Identifier:
NCT04241692
Other Study ID Numbers:
  • Pro00013642
First Posted:
Jan 27, 2020
Last Update Posted:
Jul 28, 2022
Last Verified:
Jul 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
Yes
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 28, 2022